[1]
D. Maltsev, “Effectiveness of long-term continuous immunomodulatory therapy with gamma-recombinant interferon in patients with clinically manifest forms of neutrophil myeloperoxidase deficiency”, AVFT, vol. 39, no. 5, Feb. 2021.